Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × Imatinib Mesylate × 90 days × Clear all

Sponsor

Conditions

Gastrointestinal Stromal Tumors 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Neoplasms 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Biphenotypic, Acute 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1 Carcinoma, Adenoid Cystic 1 Blast Crisis 1

Interventions

Azacitidine 14 venetoclax 12 Specimen Handling 7 Decitabine 7 Biopsy 7 fludarabine 6 Injections 6 decitabine and cedazuridine drug combination 5 Stem Cell Transplantation 5 Cytarabine 5 Cyclophosphamide 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Tacrolimus 3 Mycophenolic Acid 3 Hematopoietic Stem Cell Transplantation 3 Busulfan 3 sabatolimab 2 ruxolitinib 2 olutasidenib 2 enasidenib 2 cedazuridine 2 axatilimab 2 X-Rays 2 Vorinostat 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Idarubicin 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡